ADA: Bempedoic acid cuts MACE in statin-intolerant patients

Bempedoic acid is associated with a reduction in major adverse cardiovascular events among statin-intolerant primary prevention patients, according to a study published online June 24 in the Journal of the American Medical Association to coincide with the annual meeting of the American Diabetes Association, held from June 23 to 26 in San Diego.

Leave A Comment

Your email address will not be published. Required fields are marked *